Priya Sachdeva
Stock Analyst at UBS
(3.53)
# 2,225
Out of 4,587 analysts
15
Total ratings
90.9%
Success rate
20.7%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Priya Sachdeva
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ATRC AtriCure | Rated: Buy | $50 | $40.43 | +23.67% | 1 | Jul 28, 2026 | |
| MDT Medtronic | Upgraded: Buy | $85 → $100 | $85.52 | +16.93% | 3 | Jul 28, 2026 | |
| PEN Penumbra | Downgraded: Hold | $335 → $374 | $319.23 | +17.16% | 7 | Jan 20, 2026 | |
| NPCE NeuroPace | Maintained: Buy | $18 → $22 | $13.55 | +62.36% | 4 | Dec 16, 2025 |
AtriCure
Jul 28, 2026
Rated: Buy
Price Target: $50
Current: $40.43
Upside: +23.67%
Medtronic
Jul 28, 2026
Upgraded: Buy
Price Target: $85 → $100
Current: $85.52
Upside: +16.93%
Penumbra
Jan 20, 2026
Downgraded: Hold
Price Target: $335 → $374
Current: $319.23
Upside: +17.16%
NeuroPace
Dec 16, 2025
Maintained: Buy
Price Target: $18 → $22
Current: $13.55
Upside: +62.36%